La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Theratechnologies a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Theratechnologies..

Theratechnologies (NASDAQ:THTX) Azioni, Catena delle Opzioni

Theratechnologies

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Theratechnologies Inc

U.S. regulators approved the nation&#8217;s first 24-hour stock exchange on Wednesday, marking a significant shift in American securities trading as retail investors increasingly demand round-the-clock market access.
What Happened: The Securities and Exchange Commission granted approval to 24 Exchange, backed by Steve Cohen&#8216;s Point72 Ventures, following the startup&#8217;s second application attempt. 
The approval comes amid growing momentum for extended trading hours, with Charles Schwab Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) recently announcing plans to <a href="https://www.benzinga.com/fintech/24/10/41627496/schwab-expands-24-hour-trading-to-include-all-stocks-in-s-p-500-nasdaq-100-hundreds-of-etfs">expand 24-hour trading access</a> to all S&amp;P 500 and Nasdaq-100 stocks by 2025.
The exchange will launch in two phases, beginning with regular trading hours before expanding to overnight sessions between Sunday and Friday. A one-hour operational pause will occur during each trading day to accommodate routine software upgrades and functionality testing. 
This development follows Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) offering 24-hour trading of more than 1,000 tickers and NYSE parent Intercontinental Exchange Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) filing to extend NYSE Arca trading to 22 hours daily.
Read Next: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42237636/bitcoin-ethereum-dogecoin-simmer-down-on-thanksgiving-analyst-sees-significant-shift-from-btc-season-to-alt-season">Bitcoin, Ethereum, Dogecoin Simmer Down On Thanksgiving: Analyst Sees &#8216;Significant Shift&#8217; From BTC Season To Alt Season</a>
Why It Matters: &#8220;Traders are most at-risk when the market is closed in their geographic location,&#8221; said Dmitri Galinov, CEO and founder of 24X. &#8220;We will seek to alleviate this problem by facilitating around-the-clock U.S. equities trading.&#8221;
The approval represents a significant evolution from traditional stock trading hours, bringing equity markets closer to the continuous trading seen in cryptocurrencies and foreign exchange markets. 
The move comes after 24 Exchange&#8217;s strategic pivot from cryptocurrency trading in 2023 when it discontinued its spot crypto product amid regulatory pressures and declining interest <a href="https://www.benzinga.com/markets/cryptocurrency/23/06/32981451/steve-cohen-backed-24-exchange-pulls-the-plug-on-spot-crypto-trading-as-regulatory-pressur">following the FTX collapse</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42237909/joby-aviations-electric-air-taxi-takes-flight-in-microsoft-simulator-after-analyst-sees-3b-revenue-opportunity">Joby&#8217;s Electric Air Taxi Lands In Microsoft Flight Simulator 2024, Here&#8217;s How You Can Fly It</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a><a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Equities

News

Markets

HOOD

SCHW

SEC Approves America's First 24-Hour Stock Exchange — What It Means For You

Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) has integrated its electric air taxi into Microsoft Flight Simulator 2024, allowing aviation enthusiasts worldwide to experience the future of urban air mobility. 
What Happened: The company&#8217;s aircraft, capable of speeds up to 200 mph with zero operating emissions, is now available in the latest edition of the popular simulation game.
JoeBen Bevirt, Joby&#8217;s Founder and CEO, emphasized the significance of making their aircraft accessible to a broader audience: &#8220;We&#8217;re incredibly excited to share our revolutionary aircraft with aviation enthusiasts of all ages and backgrounds, giving everyone an opportunity to experience the intuitive and effortless controls we have designed.&#8221;
The aircraft&#8217;s implementation in the simulator is the result of extensive collaboration with Microsoft to accurately replicate its dimensions, flight physics, and unique &#8220;unified flight controls&#8221; system, similar to those used in the F-35B Joint Strike Fighter.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Joby electric air taxi is available to fly in Microsoft Flight Simulator 2024, so we put together an overview of how to fly the aircraft using one of our planned service routes as an example: JFK Airport to Downtown Manhattan (JRB). In this video, Joby software engineer and… <a href="https://t.co/ic9l642P2o">pic.twitter.com/ic9l642P2o</a>
&mdash; Joby Aviation (@jobyaviation) <a href="https://twitter.com/jobyaviation/status/1861811572793893097?ref_src=twsrc%5Etfw">November 27, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/24/11/42237670/meta-tiktok-snapchat-could-face-32m-fines-as-australia-enforces-social-media-ban-for-under-16s-while-exempting-youtube">Meta, TikTok, Snapchat Could Face $32M Fines As Australia Enforces Social Media Ban For Under-16s</a>
Why It Matters: This development comes as Needham analyst Chris Pierce initiated coverage on Joby with a Buy rating and an $8 price target. 
Pierce highlights the company&#8217;s strong market position, bolstered by its 2020 acquisition of Uber Elevate and the development of its ElevateOS platform. The analyst projects a $3 billion early-stage global air taxi revenue opportunity, with operations expected to begin in the UAE by 2025 and <a href="https://www.benzinga.com/24/11/42079908/nvidia-microstrategy-apollo-global-management-joby-aviation-and-tesla-why-these-5-stocks-are-on-investors-radars-today">U.S. regulatory approval anticipated for 2026</a>.
Joby&#8217;s strategy includes partnering with CAE to develop advanced flight simulation training devices for pilot certification. The company&#8217;s vertically integrated approach to manufacturing is expected to reduce aircraft costs and strengthen its competitive position in the <a href="https://www.benzinga.com/24/11/42071065/analyst-says-faa-support-uber-partnership-push-joby-aviation-toward-air-taxi-leadership">emerging air taxi market</a>.
The aircraft, designed to transport four passengers and a pilot, represents an advancement in urban air mobility, offering reduced noise compared to traditional helicopters while maintaining high-speed transportation capabilities. 
Investors can gain exposure to Joby through ETFs including WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/WBAT#BATS">WBAT</a>) and ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>).
Price Action: Joby Aviation stock closed at $8.00 on Wednesday, up 1.27% for the day. In after-hours trading, the stock rose an additional 0.50%. Year to date, Joby Aviation&#8217;s stock has surged 29.45%, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42237636/bitcoin-ethereum-dogecoin-simmer-down-on-thanksgiving-analyst-sees-significant-shift-from-btc-season-to-alt-season">Bitcoin, Ethereum, Dogecoin Simmer Down On Thanksgiving: Analyst Sees &#8216;Significant Shift&#8217; From BTC Season To Alt Season</a></li>
</ul>
Image via Joby Aviation
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Global

ARKX

JOBY

WBAT

Joby's Electric Air Taxi Lands In Microsoft Flight Simulator 2024, Here's How You Can Fly It

Big tech CEOs of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) have shared messages of gratitude with their followers as they celebrated Thanksgiving 2024.
What Happened: On Thursday, Apple CEO Tim Cook took to X, formerly Twitter, and expressed his thanks while highlighting the importance of health, prosperity, and the possibilities ahead.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Thanksgiving is about giving thanks for each other with the hope for health and prosperity. This year I&#39;m giving thanks for the many possibilities ahead and the people in my life—including our team at Apple, our users, and all those dedicated to making the world a better place.
&mdash; Tim Cook (@tim_cook) <a href="https://twitter.com/tim_cook/status/1862104161384575450?ref_src=twsrc%5Etfw">November 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Last month, Apple announced <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">fiscal fourth-quarter revenue </a>of $94.9 billion, surpassing analyst expectations of $94.56 billion. This marked the seventh consecutive quarter that Apple has exceeded analyst estimates for both revenue and earnings, according to <a href="http://pro.benzinga.com/">Benzinga Pro</a>.
See Also: <a href="https://www.benzinga.com/tech/24/11/42233241/jensen-huang-says-he-doesnt-love-every-day-of-his-job-heres-how-the-nvidia-boss-created-a-company-worth-over-3-trillion-today">Jensen Huang Says He Doesn&#8217;t &#8216;Love&#8217; Every Day Of His Job. Here&#8217;s How The Nvidia Boss Created A Company Worth Over $3 Trillion Today</a>
Alphabet CEO Sundar Pichai shared a simple yet heartfelt message, appreciating his family, friends, users, and colleagues worldwide.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Happy Thanksgiving! Grateful to spend time with family and friends, and for our users, partners, and Googlers around the world:)
&mdash; Sundar Pichai (@sundarpichai) <a href="https://twitter.com/sundarpichai/status/1862236073382093065?ref_src=twsrc%5Etfw">November 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In October, Alphabet also posted its <a href="https://www.benzinga.com/news/earnings/24/10/41611263/alphabet-q3-earnings-highlights-revenue-beat-eps-beat-google-cloud-up-35-momentum-across-the-compan">third-quarter revenue</a> of $88.27 billion, reflecting a 15% increase compared to the previous year. The results exceeded the consensus estimate of $86.31 billion from analysts.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Tesla and SpaceX CEO, who also owns X and xAI, Elon Musk, offered a brief but warm Thanksgiving greeting.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f1fa;&#x1f1f8;&#x1f1fa;&#x1f1f8; Happy Thanksgiving! &#x1f1fa;&#x1f1f8;&#x1f1fa;&#x1f1f8;
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1862143540912132102?ref_src=twsrc%5Etfw">November 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk's Tesla reported <a href="https://www.benzinga.com/news/earnings/24/10/41501607/tesla-q3-earnings-highlights-eps-beat-revenue-miss-shares-climb-on-2025-timeline-for-lower-cost-evs">third-quarter revenue</a> of $25.18 billion, marking an 8% year-over-year increase. However, the figure fell short of the Street consensus estimate of $25.37 billion.
Meanwhile, AMD CEO Lisa Su posted an image with a turkey and thanked her extended AMD family, friends, and fans.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Wishing everyone a very Happy Thanksgiving!!! I'm very thankful to our amazing <a href="https://twitter.com/AMD?ref_src=twsrc%5Etfw">@AMD</a> extended family, friends, and fans. Looking forward to all we will do together. &#x2764;&#xFE0F; <a href="https://t.co/eo7LWnz90Z">pic.twitter.com/eo7LWnz90Z</a>
&mdash; Lisa Su (@LisaSu) <a href="https://twitter.com/LisaSu/status/1862256282129859049?ref_src=twsrc%5Etfw">November 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
AMD posted <a href="https://www.benzinga.com/news/earnings/24/10/41612007/amd-q3-earnings-revenue-beat-eps-in-line-data-center-up-122-significant-growth-opportunities-ahead-">third-quarter revenue</a> of $6.8 billion, surpassing analyst expectations of $6.71 billion.
Photo Courtesy: Claudio Schwarz on Unsplash
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42179729/as-nvidia-maintains-chip-supremacy-jim-cramer-says-the-so-called-enemies-of-semiconductor-giant-arent-really-enemies" target="_blank" rel="noreferrer noopener">As Nvidia Maintains Chip Supremacy, Jim Cramer Says Foes Of Semiconductor Giant ‘Aren&#8217;t Really Enemies&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

AAPL

GOOG

GOOGL

TSLA

What Do Tim Cook, Sundar Pichai, Elon Musk, And Lisa Su Have In Common This Thanksgiving? Heartwarming Gratitude, Unexpected Humor, And A Turkey Or Two

Influential economist and market strategist&nbsp;Peter Schiff&nbsp;said shorting MicroStrategy Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) stock was a good idea, as he predicted potential bankruptcy for the company.
What Happened: During an interview with Kitco News that aired Thursday, Schiff called MicroStrategy a &#8220;great short&#8221; if one&#8217;s got the staying power, though he denied himself taking such a position.
&#8220;If&nbsp;you understand the dynamics of&nbsp;how this works, I mean&nbsp;you see that it can&nbsp;only end in the bankruptcy&nbsp;of MicroStrategy,&#8221; the Bitcoin critic made a bold prediction.
Making his argument, Schiff said that the company&#8217;s commitment to repay a large sum of money to c<a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them">onvertible note holders</a> could be a potential risk&nbsp;if the price of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), the asset it holds on its books,&nbsp;drops.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Bitcoin Strategic Reserve: Selling Gold for Bitcoin Is ‘Worst Monetary Mistake' US Can Make &#x7C; Schiff" width="500" height="281" src="https://www.youtube.com/embed/QRfn1h_3VYU?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42235015/chris-burniske-dismisses-supercycle-narrative-a-collective-delusion">Bitcoin &#8216;Supercycle&#8217; Narrative Is A &#8216;Collective Delusion,&#8217; Influential Crypto Venture Capitalist Says</a>
He stated that the bondholders are under the &#8220;false belief&#8221; that they have exposure to Bitcoin with no downside risk and would simply receive their money back in the worst-case situation of bankruptcy.
&#8220;Well, the problem is MicroStrategy is promising to&nbsp;pay so many&nbsp;people back so much money&nbsp;that it won&#8217;t&nbsp;be able to do it&nbsp;if the price of Bitcoin&nbsp;goes down because it doesn&#8217;t&nbsp;have the money because it&nbsp;wasted it on Bitcoin,&#8221; Schiff said. 
He predicted that the only way to repay the debt would be by selling Bitcoin.
&#8220;But as the biggest buyer and biggest owner, if it becomes the biggest seller, what happens to the price of Bitcoin? It crashes. So I think the only way this is going to end is in bankruptcy,&#8221; Schiff emphasized.
Why It Matters: Schiff&#8217;s remarks come in the wake of recent concerns raised about&nbsp;MicroStrategy and its Bitcoin investment strategy. 
Cryptocurrency analyst Willy Woo had previously flagged the potential liquidation risk of MicroStrategy due to its convertible debt offerings. He said that if the buyers of the convertible debt do not convert to shares before maturity, <a href="https://www.benzinga.com/24/11/42228264/crypto-analyst-flags-convertible-debt-induced-liquidation-risk-to-michael-saylors-microstrategy">MicroStrategy would be forced to sell Bitcoin</a> to repay the debt holders.
Additionally, investment adviser Gary Black questioned MicroStrategy&#8217;s valuation, suggesting that the company&#8217;s stock was <a href="https://www.benzinga.com/24/11/42156261/are-microstrategys-shares-worth-only-105-investment-adviser-gary-black-weighs-in">significantly overpriced</a>.&nbsp;
MicroStrategy's aggressive Bitcoin acquisition strategy has been the subject of intense media coverage in recent weeks. Last week, it outshone major companies on Wall Street <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42102652/michael-saylors-microstrategy-takes-wall-street-by-storm-becomes-second-most-traded-stock-after-nvidia">to emerge as the second-most traded stock</a> on a trading day.
Price Action: Since the beginning of November, MicroStrategy's stock has surged 69%. The company&#8217;s shares closed 9.94% higher at $388.84 on Wednesday.
Photo Courtesy: Wikimedia Commons
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42234954/will-apple-or-nvidia-be-the-worlds-most-valuable-company-by-the-end-of-2024-polymarket-traders-have-a-clear-favorite">Will Apple Or NVIDIA Be The World&#8217;s Most Valuable Company By The End Of 2024? Polymarket Traders Have A Clear Favorite</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Peter Schiff Calls MicroStrategy A 'Great Short' And Issues A Grim Warning: 'It Can Only End In Bankruptcy'

Australia has passed a <a href="https://www.benzinga.com/news/24/09/40784803/after-feud-with-elon-musk-and-mark-zuckerberg-australian-pm-anthony-albanese-set-to-ban-social-media">law banning social media</a> access for children under 16, enforcing strict penalties on Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), ByteDance-owned TikTok, and Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>).
What Happened: The <a href="https://www.benzinga.com/news/24/09/40784803/after-feud-with-elon-musk-and-mark-zuckerberg-australian-pm-anthony-albanese-set-to-ban-social-media">Social Media Minimum Age Bill</a>, approved on Thursday, prohibits minors under 16 from accessing platforms such as X, formerly Twitter, Instagram, Facebook, TikTok, and Snapchat.
Violations could result in fines of up to $32 million (AUD 49.5 million), reported Reuters.
YouTube, a subsidiary of Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, has been exempted from this ban as it is widely used in schools.
See Also: <a href="https://www.benzinga.com/news/earnings/24/11/42201885/dell-technologies-shares-drop-after-q3-revenue-misses-estimates-details?itm_source=parsely-api">Dell Technologies Shares Drop After Q3 Revenue Misses Estimates: Details</a>
In their statements to the report, spokespersons for Meta and Snap expressed concerns about the legislation.
They also promised to comply with the laws while engaging closely with the government during the 12-month implementation period.&nbsp;
Snapchat, Google, Met, and TikTok did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
The law will undergo a trial implementation phase starting January 2025, with full enforcement expected in 2026.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: The legislation has sparked a national debate. Some proponents cite the need to combat the <a href="https://www.benzinga.com/government/24/05/38751844/australia-calls-for-inquiry-into-metas-facebook-elon-musks-x-tiktok-to-make-these-platforms-accounta">negative mental health impacts</a> of social media on young people.
Critics, however, argue it may infringe on young users&#8217; rights, privacy, and access to online support networks.
The ban also follows a series of events that began with Australia&#8217;s Prime Minister Anthony Albanese&#8217;s feud with tech leaders like Elon Musk and Mark Zuckerberg.
Earlier in June, Musk's X prevailed in a <a href="https://www.benzinga.com/news/24/06/39184541/elon-musk-says-freedom-of-speech-is-worth-fighting-for-after-australia-drops-legal-battle-against-x">legal dispute with the Australian government</a> over its attempt to have footage of a church stabbing in Sydney removed.
During the same month, Meta also warned that it could restrict news content in Australia if <a href="https://www.benzinga.com/markets/equities/24/06/39542628/mark-zuckerbergs-meta-warns-it-may-block-news-content-in-australia-if-asked-to-pay-licensing-fee">required to pay licensing fees</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42208148/russian-hackers-launch-widespread-cyber-assault-using-firefox-and-windows-zero-days-what-you-need-to-know-about-the-romcom-exploit?itm_source=parsely-api">Russian Hackers Launch Widespread Cyber Assault Using Firefox And Windows Zero-Days: What You Need To Know About The RomCom Exploit</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Social Media

Politics

Media

SNAP

Meta, TikTok, Snapchat Could Face $32M Fines As Australia Enforces Social Media Ban For Under-16s

Leading cryptocurrencies powered down for Thanksgiving as signs of an incoming alt season emerged.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 8:00 p.m. ET)</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>-1.03%</td>
<td>$95,544.73</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>-2.38%</td>
<td>$3,562.08</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>-1.50%</td>
<td>$0.4002</td>
</tr>
</tbody>
</table>
</figure>
What Happened: Bitcoin oscillated within the $95,000 zone for the greater part of the day. Trading volume for the apex cryptocurrency plunged by as much as 28%.
Ethereum made a quick surge to $3,640, only to reverse course to the $3,500 range.
Bitcoin and Ethereum dominance dipped over the last 24 hours, while the market share of the rest of the altcoins rose.
Total cryptocurrency liquidations exceeded $204 million in the last 24 hours, with more than $129 million in bullish leveraged positions getting wiped out.
About $627 million in long positions risked getting liquidated if Bitcoin retraces to $93,000.
Bitcoin's Open Interest (OI) fell 1.03% in the last 24 hours, while the dominance of traders shorting the digital asset also rose, per the Long/Shorts Ratio.
The "Extreme Greed" sentiment strengthened from 77 to 78 over the last 24 hours, according to the reading of the Crypto Fear &amp; Greed Index.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 8:00 p.m. ET)</td>
</tr>
<tr>
<td>Algorand (ALGO)</td>
<td>+20.07%</td>
<td>$0.3476</td>
</tr>
<tr>
<td>The Sandbox (SAND)</td>
<td>+8.90%</td>
<td>$0.6567</td>
</tr>
<tr>
<td>Worldcoin (WLD)</td>
<td>+8.79%</td>
<td>$2.81</td>
</tr>
</tbody>
</table>
</figure>
The global cryptocurrency market capitalization stood at $3.32 trillion, contracting 0.26% in the last 24 hours.
Stock futures traded near the flatline Thursday overnight. The Dow Jones Industrial Average Futures rose 60 points, or 0.13%, as of 8 p.m. EDT.&nbsp; Futures tied to the S&amp;P 500 gained 0.08%, while Nasdaq 100 Futures added 0.07%.
Banks, post offices, shipping services, stock markets, and all the other over-the-counter markets like bond markets remained closed on the Thanksgiving holiday.&nbsp;
Stock markets will reopen on Friday to close early by 1:00 p.m. ET.
See More: <a href="https://www.benzinga.com/money/best-crypto-scanners">Best Cryptocurrency Scanners</a>
Analyst Notes: Arthur Azizov, CEO of cryptocurrency payment provider B2BINPAY, told Benzinga that the market was on the brink of a "significant shift," transitioning from Bitcoin season to alt season.
"It&#8217;s very close now, as the altseason index is already at 59, according to CoinMarketCap, which is more than half. When the index reaches 75, we can confidently say the alt season has begun. The index rises with the number of altcoins outperforming Bitcoin," Azizov remarked.
Widely-followed cryptocurrency analyst Dom's Crypto noted Bitcoin was flipping the $95,000 resistance level into support.
"This will lead to a $100,000 BTC faster than anyone thinks," the analyst forecast.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Path to $100,000 <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> is just as we &#39;speak&#39; flipping the resistance level $95,000 in to support This will lead to a $100k <a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> faster than anyone thinks &#8211; Myself included <a href="https://t.co/nWewMHEH22">pic.twitter.com/nWewMHEH22</a>
&mdash; Dom&#39;s Crypto (@Doms_Crypto) <a href="https://twitter.com/Doms_Crypto/status/1862285687195640218?ref_src=twsrc%5Etfw">November 29, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Image via Shutterstock
Read Next:    
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42235119/ethereum-outperformed-bitcoin-this-week-as-key-indicators-shift-report">Ethereum Outperformed Bitcoin This Week As Key Indicators Shift: Report</a></li>
</ul>

Movers

Trading Ideas

$DOGE

$ETH

Bitcoin, Ethereum, Dogecoin Simmer Down On Thanksgiving: Analyst Sees 'Significant Shift' From BTC Season To Alt Season

Seven &amp; i Holdings Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SVNDY#OTC">SVNDY</a>), the Japanese conglomerate that owns the global convenience store chain 7-Eleven, has become the focus of significant international investment interest. 
What Happened: U.S.-based firms Bain Capital, KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), and Fortress Investment Group have reportedly submitted bids for Seven &amp; i&#8217;s supermarket and restaurant business holding company, according to sources cited <a href="https://asia.nikkei.com/Business/Business-deals/Bain-KKR-bid-to-acquire-Seven-i-s-supermarket-business">by</a> Nikkei. 
York Holdings, Japanese trading giant Sumitomo Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSUMY#OTC">SSUMY</a>) has also joined the bidding, reflecting strong domestic competition.
York Holdings, established by Seven &amp; i in October as part of a broader corporate restructuring, is designed to streamline the company's operations. The initial round of bidding concluded Thursday, with shortlisted contenders expected to begin detailed asset evaluations in early 2025.
According to a recent NHK <a href="https://www3.nhk.or.jp/news/html/20241119/k10014643321000.html">report</a>, the founding Ito family of Seven &amp; i Holdings, the parent company of 7-Eleven, is actively pursuing plans to take the company private through a management buyout, aiming to prevent a potential takeover by a Canadian rival and consolidate control over the business within the family.
See Also: <a href="https://www.benzinga.com/24/11/42237449/mexican-president-sheinbaum-pushes-back-against-trumps-border-closure-claim-clarifies-migration-stance">Mexican President Sheinbaum Pushes Back Against Trump&#8217;s Border Closure Claim, Clarifies Migration Stance</a>
Why It Matters: The renewed investor interest follows Seven &amp; i&#8217;s rejection of a $38.5 billion acquisition offer from Alimentation Couche-Tard Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ANCTF#OTC">ANCTF</a>), the Canadian parent company of Circle K. 
Couche-Tard aimed to create the world's largest convenience store operator through the merger but faced antitrust concerns in the U.S. Despite proposing divestitures to address regulatory issues, the bid was deemed not in the best <a href="https://www.benzinga.com/markets/equities/24/09/40765790/circle-k-owner-couche-tard-pursues-talks-with-7-11-operator-seven-i-after-38-5b-bid-rejected">interests of Seven &amp; i's shareholders</a>.
Analysts, including JapanConsuming co-founder Michael Causton, have highlighted that Seven &amp; i remains undervalued due to its complex structure and corporate culture. 
Couche-Tard's strategic timing, paired with its reputation for deal-making, signals its recognition of the company&#8217;s long-term potential. However, acquiring Seven &amp; i at a lower valuation remains challenging as investor awareness of <a href="https://www.benzinga.com/markets/equities/24/09/40765790/circle-k-owner-couche-tard-pursues-talks-with-7-11-operator-seven-i-after-38-5b-bid-rejected">its intrinsic value grows</a>.
Price Action: Shares of Seven &amp; i rose 2.5% in Tokyo trading, on Friday following these developments, reflecting optimism about the company's strategic moves, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/42232990/so-you-told-your-family-to-invest-in-bitcoin-dogecoin-ethereum-at-thanksgiving-last-year-heres-how-much-they-now-have-and-why-you-might-be-invited-back-to-the-adult-table-2">So You Told Your Family To Invest In Bitcoin, Dogecoin, Ethereum At Thanksgiving Last Year? Here&#8217;s How Much They Now Have (And Why You Might Be Invited Back To The Adult Table)</a></li>
</ul>
Image via Unsplash
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

ANCTF

SSUMY

SVNDY

Japanese 7-Eleven Owner Triggers International Investor Frenzy, Attracts Bain Capital And KKR Bids

Mexican President Claudia Sheinbaum has publicly countered President-elect Donald Trump&#8216;s statement regarding Mexico&#8217;s agreement to close its border with the United States. Trump had claimed that Mexico would <a href="https://www.benzinga.com/24/11/42227649/trump-praises-wonderful-conversation-with-mexican-president-sheinbaum-she-has-agreed-to-stop-migration">immediately halt migration</a> to the U.S., a statement Sheinbaum has now addressed.
What Happened: Mexican President Claudia Sheinbaum has contested President-elect Donald Trump&#8216;s assertion that Mexico agreed to close its border with the U.S. &#8220;effectively immediately.&#8221; Sheinbaum clarified her stance in a post on X, stating that Mexico&#8217;s strategy focuses on addressing migration while respecting human rights.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">En nuestra conversación con el presidente Trump, le expuse la estrategia integral que ha seguido México para atender el fenómeno migratorio, respetando los derechos humanos. Gracias a ello se atiende a las personas migrantes y a las caravanas previo a que lleguen a la frontera.…
&mdash; Claudia Sheinbaum Pardo (@Claudiashein) <a href="https://twitter.com/Claudiashein/status/1861946615315275962?ref_src=twsrc%5Etfw">November 28, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Sheinbaum emphasized that Mexico&#8217;s approach is not about shutting borders but fostering cooperation between governments and peoples. 
Her comments were a response to Trump&#8217;s post on Truth Social, where he claimed that Mexico would halt migration to the U.S. immediately. Trump described the conversation with Sheinbaum as &#8220;wonderful,&#8221; mentioning agreements on migration and drug inflow issues.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42214089/pepe-set-to-join-dogecoin-shiba-inu-as-multi-billion-dollar-meme-coin-by-2025-massive-breakout-coming-soon-trader-predicts?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Pepe Set to Join Dogecoin, Shiba Inu As Multi-Billion Dollar Meme Coin By 2025: &#8216;Massive Breakout&#8217; Coming</a>
Why It Matters: The talks come amid Trump&#8217;s announcement of a new executive order to impose tariffs on Chinese, Canadian, and Mexican goods. The tariffs aim to pressure these countries to enhance border security and combat fentanyl exports to the U.S. Sheinbaum has warned of <a href="https://www.benzinga.com/news/global/24/11/42198583/will-trump-lead-us-into-trade-war-with-mexico-president-claudia-sheinbaum-rebukes-threats">potential counter-tariffs</a>, suggesting a tit-for-tat response that could jeopardize mutual businesses.
Earlier, Sheinbaum had addressed Trump in a letter, stating that &#8220;neither threats nor tariffs will solve the migration or the drug abuse phenomenon in the US,&#8221; advocating for collaborative solutions to the fentanyl crisis.
Furthermore, Sheinbaum has expressed concerns about a potential trade war, warning that tariffs could lead to a cycle of retaliatory measures, risking the operations of major exporters out of Mexico like General Motors Co., Stellantis NV, and Ford Motor Co.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

General

Mexican President Sheinbaum Pushes Back Against Trump's Border Closure Claim, Clarifies Migration Stance

As of today, the U.S. debt has skyrocketed to $36 trillion and around one in every five dollars the government spends goes straight into repaying investors. In addition to causing the government a great deal of trouble, this scenario is also becoming a potential stumbling block for Donald Trump&#8217;s economic ambitions and <a href="https://www.benzinga.com/24/11/42131911/donald-trump-appointed-doge-to-have-marginal-impact-saving-50-100-billion-says-analyst-as-elon-musk-aims-to-target-500-billion-plus-in-federal-expenditures">will impact</a> the new government agency headed by Musk and Ramaswamy.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
The U.S. federal debt is growing relentlessly. According to White House debt <a href="https://www.whitehouse.gov/wp-content/uploads/2023/03/hist07z1_fy2024.xlsx">data</a>, it was $19.5 trillion in 2016, shortly before Trump was elected. It <a href="https://www.benzinga.com/personal-finance/24/10/41564246/from-10-trillion-to-35-trillion-how-government-spending-has-spiraled-out-of-control">skyrocketed</a> to $26.9 trillion by 2020 and now is nearly <a href="https://www.crfb.org/press-releases/gross-national-debt-reaches-36-trillion">$36 trillion</a>. "The point is that fiscal policy reflects joint action by Congress and the president," David Primo, a University of Rochester professor of political science and business administration, told AP. This directly impacts how the government functions, so it&#8217;s not just about numbers.
According to the <a href="https://www.fiscal.treasury.gov/files/reports-statements/mts/mts0824.pdf">Congressional Budget Office</a> (CBO), interest payments alone will total more than $1 trillion in the upcoming year. The government intends to spend less on national security than on these payments. What&#8217;s worse, rising debt service costs are crowding out essential programs like infrastructure, education and health care – areas that are supposed to contribute to future growth.
See Also: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
<h2 class="wp-block-heading">Big Promises, Bigger Obstacles</h2>
Trump has talked about big economic plans, including <a href="https://www.benzinga.com/government/regulations/24/11/41885777/how-trumps-tax-cuts-tariffs-animal-spirits-could-shape-sp-500-earnings">tax cuts and tariffs</a>. But the rising cost of paying off existing debt means there's less room for these moves. The costs of servicing this huge debt leave Trump with fewer options for ambitious economic measures. Increased debt restricts the federal budget&#8217;s flexibility, making it more difficult to enact tax cuts that Trump claims would help the middle class.
Critics argue that Trump&#8217;s proposed tax cuts, like those from 2017, largely benefit the wealthiest Americans and <a href="https://www.benzinga.com/government/24/06/39462030/trump-added-nearly-two-times-more-to-the-national-debt-than-biden-while-in-office-new-report">add to the already ballooning debt</a>. Additionally, rising national debt tends to raise interest rates, making it more expensive for Americans to purchase houses, vehicles or make long-term investments.&nbsp;
Trending: Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
<h2 class="wp-block-heading">The Forces Pulling Interest Rates</h2>
Jeffrey Schmid, the president of the Kansas City Fed, has recently stressed that <a href="https://www.benzinga.com/24/11/42075235/feds-schmid-rising-us-national-debt-could-push-interest-rates-higher">three significant factors</a> influence interest rates: growing debt, an aging population and productivity growth. Productivity gains, especially driven by new tech like AI, could mean higher rates. However, an aging population and the tendency of older generations to save more could push rates lower. &#8220;While now is the time to begin dialing back the restrictiveness of monetary policy, it remains to be seen how much further interest rates will decline or where they might eventually settle,&#8221; Schmid said.
With a $36 trillion bill, the government must keep attracting investors to buy its bonds, which will mean offering higher interest rates.
Without major adjustments, the national debt will continue destabilizing the economy, making it even harder for investors and the government to take risks. The effectiveness of this new agency&#8217;s cost-cutting initiatives will change in conjunction with interest rate fluctuations. The ongoing question is whether productivity and new technology can save the day or if the growing debt will push rates further, limiting economic growth and complicating the agency&#8217;s mission to streamline spending.
Read Next:
<ul>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

Personal Finance

1 In 5 Dollars The Government Expends Goes To Repaying Investors. Here's Why This Spells Trouble For Trump And DOGE

France maintains one of the strictest cannabis policies in Europe, prohibiting recreational use, possession and cultivation. Paradoxically, it also has the highest <a href="http://benzinga.com/cannabis">cannabis</a> consumption rate on the continent. As the French government grapples with mounting public debt –currently at 112% of GDP– legalizing and taxing cannabis presents a potential fiscal lifeline.  
<h3 class="wp-block-heading">France Could Unlock Major Gains By Legalizing</h3>
The country&#8217;s stringent laws lead to significant law enforcement costs and strain on the judicial system. <a href="https://www.theguardian.com/commentisfree/2024/nov/27/france-cannabis-consumption-europe-tax-decriminalisation-crime">According</a> to The Guardian, approximately 200,000 people pass through the criminal justice system annually on drug-related charges, with substantial resources allocated to anti-cannabis efforts.
However, economic analysts consulted by The Guardian suggest that legalizing cannabis could alleviate France&#8217;s financial challenges. A 2019 <a href="https://shs.cairn.info/revue-notes-du-conseil-d-analyse-economique-2019-4-page-1?lang=fr#s1n7">study</a> by an economic advisory board within the Prime Minister&#8217;s office estimated that legalization could generate €2.8 billion ($2.9 billion) in fiscal receipts and create up to 80,000 jobs.
<h3 class="wp-block-heading">High Anti-Cannabis Costs Amid Economic Strain</h3>
Legalization proponents argue it could also reduce gang-related crime by removing a lucrative market from criminal networks. Moreover, regulated sales might undercut illegal dealers and decrease street violence associated with drug trafficking.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
These revenues, combined with savings on enforcement costs, could also provide much-needed relief as the government contemplates unpopular tax hikes and spending cuts. With national debt at €3.2 trillion and a budget deficit projected at 6% for 2024, cannabis could offer France a much-needed financial boost.
<h3 class="wp-block-heading">Future of French Medical Cannabis In Limbo</h3>
Meanwhile, despite the potential benefits of legalizing, France&#8217;s medical marijuana trial <a href="https://www.benzinga.com/markets/cannabis/24/10/41503963/frances-medical-marijuana-trial-faces-uncertainty-as-new-amendment-tries-to-keep-it-running">faces delays and political uncertainty</a>. Originally set to end in March 2024, the program now hinges on a proposed amendment to extend it through 2025. Political delays have prevented alignment with European regulations, leaving the future of medical cannabis in limbo.&nbsp;
Without immediate action, over 2,000 patients could lose access to treatments, highlighting the need for a permanent framework.&nbsp;&nbsp;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/04/38029760/cannabis-on-the-rise-in-europe-why-germanys-legalization-is-a-game-changer-for-the-ecosystem">Cannabis On The Rise In Europe: Why Germany&#8217;s Legalization Is A Game Changer For The Ecosystem</a>
<h3 class="wp-block-heading">Neighbors Diverge: Germany Lights Up</h3>
In contrast, Germany's cannabis market exemplifies a more progressive approach. Its Cannabis Control Act, enacted earlier this year, has spurred rapid growth. Sanity Group, a leading German cannabis company, <a href="https://www.benzinga.com/markets/cannabis/24/10/41336543/is-germany-set-to-become-next-cannabis-giant-we-tripled-within-one-year-says-industry-insider">reported tripling its revenue within a year</a> due to regulatory changes. Germany's potential expansion into adult-use cannabis could further establish it as Europe's cannabis leader.&nbsp;&nbsp;
With <a href="https://www.benzinga.com/markets/cannabis/24/11/42043465/czech-government-legalizes-cultivation-of-three-cannabis-plants-allows-possession-of-50-grams">evidence from neighboring countries</a> and <a href="https://www.benzinga.com/markets/cannabis/22/04/26520421/majority-of-europeans-support-cannabis-legalization-which-country-will-do-something-about-it">growing public discourse</a>, France faces increasing pressure to reconsider its strict policies. Legalization could not only address fiscal challenges but also position France as a competitor in the burgeoning European cannabis industry.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42162875/canopy-growths-german-subsidiary-teams-up-with-portugals-gro-vida-to-expand-medical-cannabis-supply">Canopy Growth&#8217;s German Subsidiary Teams Up With Portugal&#8217;s Gro-Vida To Expand Medical Cannabis Supply</a></li>
</ul>
Image generated with AI tools.

Cannabis

Eurozone

Europe's Top Cannabis Consumer Still Criminalizes Use, Forfeits Economic Gains

Planning to <a href="https://www.benzinga.com/personal-finance/24/09/40964924/most-people-expect-to-retire-at-67-but-56-retire-sooner-can-you-guess-the-actual-average-retirem">retire at a specific age</a> often involves careful preparation, but reality doesn't always align with expectations. A new study by the Employee Benefit Research Institute (EBRI) found that 58% of retirees leave the workforce earlier than planned, frequently due to factors beyond their control.
EBRI's 2024 Spending In Retirement study, which surveyed 3,600 retirees aged 62 to 75, reveals some of the reasons for early retirement and the financial challenges that come from it.&nbsp;
Don't Miss:
<ul>
<li>The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a></li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
<h2 class="wp-block-heading">Why Do People Retire Early?</h2>
For some, <a href="https://www.benzinga.com/personal-finance/24/10/41185972/is-65-too-early-to-retire-new-research-says-it-might-be-45-of-households-are-expected-to-run-out">retiring early</a> is a strategic choice. They've built their nest egg and have methodically planned for early retirement. For others, it isn't always within their control.&nbsp;
Health issues and workplace reorganization are the leading factors behind why many Americans retire early. According to the EBRI survey:&nbsp;
<ul>
<li>38% of those who retired earlier than expected cited health problems or disabilities as the main reason. </li>
<li>23% stated that company-related issues like downsizing, closures or reorganizations were the cause. </li>
</ul>
Roughly two out of five of those who retired early did so because they felt financially prepared. However, this group represents a minority compared to those whose circumstances necessitated an earlier exit.&nbsp;
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
<h2 class="wp-block-heading">Financial Struggles Among Early Retirees</h2>
Leaving the workforce sooner than expected can have negative financial implications. Early retirees have less time to <a href="https://www.benzinga.com/personal-finance/24/11/41918104/are-you-on-track-to-retire-rich-heres-the-nest-egg-you-need-to-be-considered-a-wealthy-retiree">save for retirement</a>, requiring them to stretch their existing savings across a longer period of time.&nbsp;
A similar study by John Hancock Financial found that early retirees are more likely to face financial stress for several reasons:&nbsp;
<ul>
<li>33% of those who retire early rely solely on Social Security for their income, compared to just 11% of those who retired when they planned.</li>
<li>Over half reported cutting back on spending and 45% downsized their living arrangements to reduce costs.</li>
<li>With longer life expectancy, Americans must plan for funding a retirement that could span multiple decades, extending longer if they retire early. </li>
</ul>
The EBRI study also revealed that many retirees are unprepared for the financial demands of retirement. Half of retirees said they did not save as much as they needed and only one-third thought they had enough.&nbsp;
Trending: <a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a>
<h2 class="wp-block-heading">A Broader Retirement Reality</h2>
Despite the financial challenges, many retirees remain optimistic. Two-thirds of respondents in the EBRI study said they are living the retirement lifestyle they envisioned, even if getting there was difficult.
However, the findings from this study highlight an important lesson: while planning for the age you want to retire at is important, unforeseen circumstances can disrupt even the best-laid plans. Health issues, workplace changes and <a href="https://www.benzinga.com/personal-finance/24/09/40800774/gen-xs-looming-retirement-crisis-is-worse-than-they-realize-expert-compares-it-to-being-handed-a">insufficient savings</a> are all risks that retirees should prepare for to ensure a more secure financial future.
For those still working, start planning early and revisit your savings goals frequently to help mitigate challenges that may come if you must unexpectedly retire.&nbsp;
Read Next:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

EBRI Study Reveals 58% Of Retirees Retire Earlier Than Expected, Here's Why

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 68.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 25.00% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 16.78% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 10.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 8.70% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 8.11% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 6.48% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed up 4.24% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.33% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.31% at $1.94</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 3.07% at $1.76</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MPXOF">MPX International</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPXOF#OTC">MPXOF</a>) shares closed down 33.33% at $0.0002</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 32.15% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 31.19% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 30.82% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 14.71% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 10.60% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 9.20% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 6.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 5.80% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 3.96% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed down 3.90% at $0.08</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBRRF

BMMJ

CLSH

CNBX

CNPOF

CNTMF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CWBHF

EAST

GBHPF

KAYS

LMLLF

LVRLF

MGWFF

MPXOF

NWVCF

RMHB

RSSFF

TGIFF

XXII

YCBD

Cannabis Stock Movers For November 28, 2024

Berkshire Hathaway Inc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) stock soared to unprecedented levels, closing Wednesday at $483.08 after touching a 52-week high of $491.67. 
<h2 class="wp-block-heading">Berkshire's Stock Surges to New Heights</h2>
The stock has been on a tear, boasting a 34% gain over the past year and 19.6% in the last six months. 
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="628" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28132715/Screenshot-2024-11-28-at-11.57.02-PM.png" alt="" class="wp-image-669243" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28132715/Screenshot-2024-11-28-at-11.57.02-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28132715/Screenshot-2024-11-28-at-11.57.02-PM-300x234.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112824&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
With its price trading well above key moving averages—including a 200-day SMA of $430.63—technical indicators suggest the bullish trend is intact.
However, with the Relative Strength Index (RSI) at 68.79, the stock is teetering near overbought territory, raising questions about sustainability. Despite this, a Moving Average Convergence Divergence (MACD) reading of 5.56 signals continued strength.
Read Also: <a href="https://www.benzinga.com/personal-finance/24/11/42191171/warren-buffett-claims-he-killed-the-dow-investing-peanuts-and-explains-its-a-huge-structural-advantage-to-not-have-a-lot-of-money">Warren Buffett Claims He &#8216;Killed The Dow&#8217; Investing &#8216;Peanuts&#8217; – And Explains It&#8217;s A &#8216;Huge Structural Advantage To Not Have A Lot Of Money&#8217;</a>
<h2 class="wp-block-heading">Buffett's Generosity Knows No Bounds</h2>
Even as his net worth hits $150 billion, <a href="https://www.benzinga.com/topic/warren-buffett">Warren Buffett</a> isn't slowing down his philanthropic mission. On Monday, the Oracle of Omaha pledged another $1.15 billion worth of Berkshire stock to his family's charitable foundations, continuing his 2006 commitment to give away most of his wealth.
Buffett has now donated 56.6% of his Berkshire shares, solidifying his legacy as both an investing icon and a philanthropic force. His latest move follows a colorful shareholder<a href="https://www.businesswire.com/news/home/20241125323423/en/Berkshire-Hathaway-Inc.-News-Release"> letter</a>, where he reaffirmed his dedication to wealth redistribution.
<h2 class="wp-block-heading">A Wealth Legacy Like No Other</h2>
Buffett, who <a href="https://www.forbes.com/sites/dereksaul/2024/11/25/never-wished-to-create-a-dynasty-warren-buffett-donates-11-billion-in-berkshire-stock-and-updates-will/">ranks</a> as the sixth-richest person in the world, has more than doubled his fortune since 2014. Yet, he trails Elon Musk's $330 billion net worth by a significant margin. Unlike Musk's splashy ventures, Buffett's wealth engine—Berkshire Hathaway—continues its steady climb, reinforcing its position as a titan of diversified investing.
Investors are left wondering: can Berkshire maintain its momentum, or is the stock's RSI warning of a potential pullback? Either way, one thing remains clear: Buffett's empire isn't just breaking records—it's making history.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/42143260/warren-buffett-claims-to-not-time-the-market-but-his-cash-horde-tells-a-different-story">Warren Buffett Claims To Not &#8216;Time The Market,&#8217; But His Cash Horde Tells A Different Story</a></li>
</ul>

Long Ideas

Technicals

Warren Buffett's Billion-Dollar Moves Propel Berkshire Stock To Record Highs

The commercial aerospace sector is gaining altitude, driven by surging demand for passenger travel, robust freight activity, and a <a href="https://www.benzinga.com/topic/expert-ideas">resurgence in aircraft orders</a>.
According to Goldman Sachs analyst Noah Poponak, CFA, air traffic recovery is exceeding expectations, with growth now outpacing GDP by more than double. 
The sector&#8217;s strong fundamentals, buoyed by tight supply chains and rising aftermarket revenues, are positioning key aerospace stocks for a significant takeoff.
Here&#8217;s what you need to know — and the top stocks analysts say you should have on your radar.
<h3 class="wp-block-heading">Air Traffic Surpasses Pre-Pandemic Levels</h3>
&#8220;The overall commercial aerospace market is fundamentally strong,&#8221; said Poponak in a note Thursday. 
Global passenger traffic continues its remarkable climb as international air traffic jumped 9% year-over-year (yoy) in September, following an 11% yoy increase in August, according to the International Air Transport Association (IATA). Passenger capacity rose in lockstep, up 9% and 10% yoy, respectively.
Goldman Sachs forecasts another 9% yoy gain for October based on airline reports. 
Forward airline schedules indicate that global passenger capacity will grow by 6% to 7% year-over-year through November, December, and January, reflecting sustained demand as travel appetite remains strong.
<h3 class="wp-block-heading">Freight Market Delivers Double-Digit Growth</h3>
The recovery isn't limited to passengers. International freight traffic surged 11% yoy in September, following a 12% yoy gain in August, with freight capacity expanding by 8% yoy in both months. 
Major cargo players FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) and United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) also saw gains, with UPS reporting 11% yoy growth and FedEx posting a 3% yoy increase in global air cargo traffic.
<h3 class="wp-block-heading">Boeing, Airbus Rack Up Orders</h3>
Large commercial jet manufacturers are riding the wave of demand. In October alone, Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) secured 63 new orders, while Airbus SE (OTCPK: EADSY) booked 82 aircraft orders—both with zero cancellations. 
&#8220;New aircraft order campaigning activity appears to remain robust, for both growth and replacement,&#8221; Poponak wrote. 
Parked aircraft, which currently make up 11.8% of the total global fleet, remained flat month-over-month, further reflecting high utilization levels as airlines capitalize on the recovery in passenger and freight traffic.
<h3 class="wp-block-heading">Goldman Sachs' Top Stock Picks</h3>
Goldman Sachs&#8217; Poponak highlighted 11 buy-rated stocks that stand to benefit from the industry's resurgence. These include large aircraft manufacturers, component suppliers, and business jet producers.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Category</th>
</tr>
</thead>
<tbody>
<tr>
<td>Woodward Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>)</td>
<td>Aerospace Systems</td>
</tr>
<tr>
<td>Boeing Co.</td>
<td>Large Aircraft</td>
</tr>
<tr>
<td>TransDigm Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>)</td>
<td>Aircraft Components</td>
</tr>
<tr>
<td>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>)</td>
<td>Engine Manufacturing</td>
</tr>
<tr>
<td>HEICO Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>)</td>
<td>Aircraft Parts</td>
</tr>
<tr>
<td>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>)</td>
<td>Aerospace Materials</td>
</tr>
<tr>
<td>Ducommun Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCO#NYSE">DCO</a>)</td>
<td>Aerospace Electronics</td>
</tr>
<tr>
<td>CAE Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAE#NYSE">CAE</a>)</td>
<td>Simulation &amp; Training</td>
</tr>
<tr>
<td>Bombardier Inc. (OTCPK: BOMBF)</td>
<td>Business Jets</td>
</tr>
<tr>
<td>Embraer S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>)</td>
<td>Regional Aircraft</td>
</tr>
<tr>
<td>Textron Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) </td>
<td>Business Jets &amp; Helicopters</td>
</tr>
</tbody>
</table>
</figure>
Among these, Woodward (WWD) is singled out for its placement on Goldman's &#8220;Conviction List,&#8221; while Boeing remains a flagship name for its leadership in large commercial jets.

Analyst Color

Large Cap

Mid Cap

BOMBF

European Aeronautic Defence And Space Unsponsored

EADSY

Embraer-Empresa Brasileira De Aeronautica

Aerospace Ready To Take Off: Goldman Sachs Reveals 11 Top Picks In The Sector

In the current session, the stock is trading at $139.73, after a 0.62% spike. Over the past month, Live Nation Entertainment Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) stock increased by 19.28%, and in the past year, by 65.85%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1732824015_0.png" alt="Past Year Chart" />

<h3>Comparing Live Nation Entertainment P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Live Nation Entertainment has a better P/E ratio of 156.03 than the aggregate P/E ratio of 41.7 of the Entertainment industry. Ideally, one might believe that Live Nation Entertainment Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1732824016_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for Live Nation Entertainment

For income-focused investors, <a href="https://www.benzinga.com/real-estate/reit">real estate investment trusts (REITs)</a> are a goldmine, offering steady dividends backed by tangible assets. 
Our search for top REITs focused on large-cap stocks from the S&amp;P 500 index with a dividend yield exceeding 5% and Wall Street analysts rating them a "Buy" or higher. This rigorous filter led us to three standout picks that combine high yield with growth potential. From healthcare facilities to retail and casinos, these REITs provide both robust income and diversified exposure.
<h2 class="wp-block-heading">1. Healthpeak Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>): A Prescription For Income</h2>
Dividend Yield: 5.40% Market Cap: $15.81 billion Sector: Healthcare Facilities
Healthpeak Properties is a healthcare-focused REIT with a flair for stability and growth. Offering a 5.40% dividend yield, DOC has seen a stellar 30.67% performance over the past year and 12.32% year-to-date gains. Its price-to-free-cash-flow (P/FCF) ratio of 18.41 signals a fair valuation, making it an attractive choice for yield-seeking investors.
With the healthcare sector&#8217;s resilience, Healthpeak benefits from long-term demographic trends like aging populations, positioning itself as a dependable dividend payer in a defensive industry.
Read Also: <a href="https://www.benzinga.com/real-estate/reit/24/11/42068836/crowdstreets-new-ceo-john-imbriglia-charts-a-bold-path-for-commercial-real-estate-investors">CrowdStreet&#8217;s New CEO John Imbriglia Charts a Bold Path for Commercial Real Estate Investors</a>
<h2 class="wp-block-heading">2. Realty Income Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>): The Monthly Dividend Machine</h2>
Dividend Yield: 5.37% Market Cap: $51.55 billion Sector: Retail
Nicknamed "The Monthly Dividend Company," Realty Income is a household name in income investing. Offering a 5.37% yield, O maintains a strong foothold in retail real estate, with a portfolio diversified across industries and tenants. Despite modest performance year-to-date (1.57%), its P/FCF of 15.84 underscores solid fundamentals.
Realty Income's consistent payouts and reputation for reliable income make it a cornerstone for dividend-focused portfolios. Whether the market&#8217;s hot or cold, this REIT remains a fan favorite for its unwavering commitment to shareholder returns.
<h2 class="wp-block-heading">3. VICI Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>): A Jackpot For Investors</h2>
Dividend Yield: 5.20% Market Cap: $34.60 billion Sector: Diversified
VICI Properties owns an enviable portfolio of casino and gaming assets, including Las Vegas landmarks. Its 5.20% dividend yield is paired with a P/FCF of 15.01, making it the most attractively valued among our picks. Over the past six months, VICI has outperformed with a 16.18% gain, outpacing broader market indices.
As the gaming industry recovers post-pandemic, VICI is well-positioned to capture growth while rewarding investors with consistent income. With its diversified exposure and high yield, this REIT is a safe bet for any portfolio.
These REITs—Healthpeak, Realty Income, and VICI Properties—combine strong dividend yields with promising growth, backed by Wall Street's confidence. 
Whether you're looking for healthcare stability, retail reliability, or a gamble on casinos, these large-cap REITs deliver income with the potential for capital appreciation. For investors, the choice is clear: when it comes to dividends, these are the real estate crown jewels.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/real-estate/reit/24/11/42044923/goldman-sachs-turns-bearish-on-redfin-affordability-could-weigh-on-a-housing-recovery">Goldman Sachs Turns Bearish On Redfin: &#8216;Affordability Could Weigh On A Housing Recovery&#8217;</a></li>
</ul>

REIT

Dividends

Real Estate

VICI

High-Yield REITs To Watch: Three Wall Street-Approved S&P 500 Gems

Leidos Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) short percent of float has risen 29.05% since its last report. The company recently reported that it has 1.91 million shares sold short, which is 1.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.05 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Leidos Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732822222_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Leidos Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Leidos Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Leidos Holdings's peer group average for short interest as a percentage of float is 3.04%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

LDOS

(LDOS) - Analyzing Leidos Holdings's Short Interest

Roku's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NYSE">ROKU</a>) short percent of float has risen 40.13% since its last report. The company recently reported that it has 12.52 million shares sold short, which is 11.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Roku Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732822217_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Roku has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Roku's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Roku's peer group average for short interest as a percentage of float is 8.39%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ROKU

Peering Into Roku's Recent Short Interest

Israel's ceasefire agreement with Hezbollah which entered into force on Wednesday appears to be unraveling after alleged violations by the Lebanese militant group prompted <a href="https://www.benzinga.com/topic/israel">an Israeli military response</a>.
According to the Israel Defense Forces (IDF), a Hezbollah-linked facility in southern Lebanon was targeted in an airstrike on Thursday after suspicious activity was identified. 
The site reportedly housed medium-range rockets, which were deemed a potential threat.
<h3 class="wp-block-heading">IDF&#8217;s Response To Alleged Breaches</h3>
IDF spokesperson Avichay Adraee announced on X that several suspects, some traveling in vehicles, were spotted entering multiple areas in southern Lebanon, violating the ceasefire agreement. IDF forces responded by opening fire on the group.
Adraee further stated that &#8220;terrorist activity was detected at a Hezbollah site in southern Lebanon, which contained medium-range rockets.&#8221; He confirmed that Israeli warplanes carried out a strike to neutralize the threat.
&#8220;The IDF is deployed in southern Lebanon and is actively working to prevent any violations of the ceasefire agreement,&#8221; Adraee added.
He also issued a warning to residents of southern Lebanon, emphasizing that movement south of the Litani River is strictly prohibited between 5 p.m. and 7 a.m. local time.
Separately, Avital Leibovich, director of the American Jewish Committee Israel Office, highlighted that Hezbollah operatives had entered the village of Kfarkela near the Israeli border, where they are prohibited under the agreement. In response, IDF forces fired warning shots toward the group.
<h3 class="wp-block-heading">Markets React To Renewed Middle East Tensions</h3>
Commodities showed reactions following the latest headlines in Middle East. 
Oil futures rose 0.5% on Thursday, with West Texas Intermediate (WTI) prices – tracked by the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) – climbing to $68.9 a barrel, marking a potential end to a three-day losing streak. 
Gold futures edged up 0.4%, continuing a strong rally. The precious metal is now eyeing its sixth consecutive positive session as investors turn to safe-haven assets amid geopolitical uncertainty.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42225506/canada-prepares-retaliatory-tariffs-as-trumps-threat-looms-analysts-warn-of-further-loonie-weakness">Canada Prepares Retaliatory Tariffs After Trump Threats: Analysts Warn Of Further Loonie Weakness</a></li>
</ul>
Image: Shutterstock

Commodities

Econ #s

Israel-Hezbollah Ceasefire Violations Spark Tensions, IDF Strikes Southern Lebanon: Oil Prices Surge

Recursion Pharmaceuticals's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NYSE">RXRX</a>) short percent of float has fallen 26.22% since its last report. The company recently reported that it has 64.57 million shares sold short, which is 18.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.24 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Recursion Pharmaceuticals Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732822212_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Recursion Pharmaceuticals has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Recursion Pharmaceuticals's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Recursion Pharmaceuticals's peer group average for short interest as a percentage of float is 10.99%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

RXRX

(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest

The healthcare industry is growing massively owing to new drugs and technological innovations. Thus, investing in fundamentally robust small-cap stocks Theratechnologies (THTX), Anika Therapeutics. (ANIK), and SIGA Technologies (SIGA) could be a good idea. Read more to find out… The healthcare industry plays a major economic role by providing essential products and services that enhance people's health and well-being. Recent years have brought significant changes to the sector, driven by technological advancements, personalized healthcare, and biotechnological innovations.
Amid this, it could be wise to invest in fundamentally sound small-cap healthcare stocks Theratechnologies (<a href="https://stocknews.com/stock/THTX/">THTX</a>), Anika Therapeutics (<a href="https://stocknews.com/stock/ANIK/">ANIK</a>), and SIGA Technologies (<a href="https://stocknews.com/stock/SIGA/">SIGA</a>). With a market capitalization of <a href="https://www.investopedia.com/terms/s/small-cap.asp">up to $2 billion</a>, these companies offer greater growth potential than large-cap firms and could be valuable additions to one's portfolio.
Over the last decade, significant advancements in survival rates and patient quality of life have greatly benefited the healthcare industry. These improvements stem from the intersection of medical and technological breakthroughs, which have enhanced the effectiveness of healthcare delivery and treatment outcomes.
Integrating high-tech diagnostic and therapeutic equipment with clinical practices has significantly improved healthcare outcomes. Innovations such as telemedicine, robotic process automation, and remote patient monitoring are <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10993086/">transforming patient care</a> by making it more efficient and accessible, benefiting the sector.
The continuous introduction of new drugs also benefits the industry by expanding treatment options and improving patient care. The U.S. Food and Drug Administration's <a href="https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024">approval of 23 new drugs</a> this year for various chronic conditions illustrates the sector's growth potential and capacity to advance medical treatments.
According to a report by Precedence Research, the global biotechnology market is expected to grow at <a href="https://www.precedenceresearch.com/biotechnology-market#:~:text=The%20U.S.%20biotechnology%20market%20size%20was%20valued%20at,a%20CAGR%20of%2011.90%25%20from%202024%20to%202033.">a CAGR of 11.8%</a>, reaching approximately $4.25 trillion by 2033. This growth signifies increased investment and innovation, driving further advancements and improvements in patient care.
Considering these factors, let's explore the fundamentals of three promising small-cap healthcare stocks, starting with #3.
Stock #3: Theratechnologies Inc. (<a href="https://stocknews.com/stock/THTX/">THTX</a>)
THTX, based in Montreal, Canada, has a market capitalization of $62.76 million and develops therapies that address unmet medical needs. Its pipeline includes the F8 Formulation in Phase 2b/3 trials for tesamorelin in treating nonalcoholic steatohepatitis, a multi-dose pen injector for tesamorelin administration, and more.
On May 23, THTX reported <a href="https://www.theratech.com/news-releases/news-release-details/theratechnologies-sudocetaxel-zendusortide-asco-2024">Phase 1 data</a> for its investigational peptide drug conjugate, sudocetaxel zendusortide (TH1902). The data showcased promising long-term efficacy and a manageable safety profile in patients with solid tumors, highlighting the potential of TH1902 in advancing cancer treatment.
This could position THTX favorably for future development stages and regulatory approval.
On April 8, THTX showcased preclinical data <a href="https://www.theratech.com/news-releases/news-release-details/theratechnologies-preclinical-data-presentation-aacr-2024">demonstrating the versatility</a> of its SORT1+ Technology&#x2122; platform. The data revealed that camptothecin-peptide conjugates effectively regress tumors in colorectal cancer (CRC) and triple-negative breast cancer (TNBC) models.
The validation could boost THTX's growth by confirming the platform's broad application and efficacy. The promising results could attract potential partners and investors, positioning THTX as a leader in innovative cancer treatments and accelerating its path to clinical development and market success.
For the fiscal 2024 second quarter that ended May 31, 2024, THTX reported revenue of $22.02 million, indicating a 25.5% year-over-year increase. Its profit from operating activities was $3.29 million compared to a loss of $7.94 million in the previous year's quarter.
Moreover, the company reported a <a href="https://www.investopedia.com/terms/n/netincome.asp">net income</a> and income per share of $987 thousand and $0.02, compared to a loss and loss per share of $10.01 million and $0.41 in the prior year's period.
Street expects THTX's revenue to rise 15.2% year-over-year to $23.94 million in the fiscal 2024 third quarter ending in August. The company's EPS is expected to be $0.04. Moreover, THTX has surpassed the consensus EPS estimates in three of the four trailing quarters.
Shares of THTX have gained 8.3% over the past three months and 1.11% over the past nine months to close the last trading session at $1.37.
THTX's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its promising outlook. The stock has an overall rating of B, which equates to a Buy in our proprietary rating system. The POWR Ratings are calculated considering 118 different factors, each weighted optimally.
THTX stock has an A grade for Growth and a B for Value and Sentiment. It is ranked #27 in the 639-stock <a href="https://stocknews.com/category/biotech/">Biotech</a> industry.
Beyond what is stated above, we've also rated THTX for Quality, Momentum, and Stability. <a href="https://stocknews.com/stock/THTX/">Click here</a> to get all THTX ratings.
Stock #2: Anika Therapeutics, Inc. (<a href="https://stocknews.com/stock/ANIK/">ANIK</a>)
Valued at $374.21 million, ANIK is a joint preservation company that develops and markets products using hyaluronic acid technology. Its product family includes Monovisc and Orthovisc for pain management, joint preservation solutions like Integrity and Hyalofast, Arthrosurface for sports medicine, and non-orthopedic products like adhesion barrier and wound care.
On July 11, ANIK announced <a href="https://ir.anika.com/Anika-Announces-Full-Market-Release-of-the-Integrity-TM-Implant-System,-a-Regenerative-Hyaluronic-Acid-Based-Scaffold-for-Rotator-Cuff-and-Other-Tendon-Repairs">a full market release</a> of its Integrity Implant System across the United States. The Integrity System includes a hyaluronic acid-based implant with bone and tendon fixation components and ingenious one-time use arthroscopic delivery instruments and is made to protect an injured tendon and propagate healing in rotator cuff repair and other tendon procedures
The positive feedback from the limited release underscores Integrity's clear advantages over collagen patches. Initially focused on rotator cuff repairs, Integrity's versatility has been proven in diverse applications, including Achilles tendon and foot repairs. This breakthrough positions ANIK as a leader in advancing surgical outcomes, driving its growth and reputation.
For the fiscal 2024 second quarter, which ended June 30, 2024, ANIK reported revenue of $41.92 million. The company's adjusted gross profit amounted to $27.52 million, while it registered an adjusted EBITDA of $6.29 million, indicating a marginal year-over-year increase.
Furthermore, ANIK's income from operations amounted to $161 thousand compared to a loss of $3.63 million in the previous year's quarter.
Analysts predict ANIK's revenue for the fiscal fourth quarter ending December 2024 to increase 5.8% year-over-year to $45.45 million. Its EPS for the same quarter is expected to grow 530% from the prior year's quarter to $0.32.  Moreover, the company surpassed consensus revenue estimates in all four trailing quarters.
The stock has gained 7.2% over the past six months and 20% over the past nine months to close the last trading session at $25.29.
ANIK's robust fundamentals are reflected in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
ANIK has a B Growth and Stability. It is ranked #23 out of 639 stocks in the Biotech industry.
In addition to the POWR Ratings we've stated above, we also have ANIK ratings for Momentum, Value, Sentiment, and Quality. Get all ANIK ratings <a href="https://stocknews.com/stock/ANIK/">here</a>.
Stock #1: SIGA Technologies, Inc. (<a href="https://stocknews.com/stock/SIGA/">SIGA</a>)
With a market capitalization of $854.29 million, SIGA is a commercial-stage pharmaceutical firm focused on health security, including countermeasures for biological, chemical, radiological, and nuclear threats. Its lead product, TPOXX, is an antiviral drug available in oral and IV forms for treating human smallpox disease.
On July 19, SIGA announced that the U.S. Department of Health and Human Services had exercised <a href="https://investor.siga.com/investors/news/news-details/2024/SIGA-Announces-U.S.-Government-Procurement-Order-of-113-Million-for-Oral-TPOXX/default.aspx">a $113 million procurement option</a> for oral TPOXX&#xAE; treatment courses. The substantial order builds on 2023's orders from the U.S. government and 15 international customers.
The consistent support from government and international customers could enhance SIGA's market position and credibility, paving the way for continued innovation and readiness against biological threats.
On June 17, SIGA announced an agreement to <a href="https://investor.siga.com/investors/news/news-details/2024/SIGA-Announces-Agreement-to-Sell-TPOXX-to-ASEAN-Member-States-06-17-2024/default.aspx">expand access to TPOXX (tecovirimat)</a> across the ASEAN member states, a political and economic union in Southeast Asia. The agreement would help SIGA establish a presence in a densely populated area and lay the foundation for future developments.
SIGA's total revenue for the fiscal 2024 second quarter, which ended June 30, 2024, amounted to $21.81 million, showing a 270.9% year-over-year growth. The company's net income and EPS were $1.83 million or $0,03 per share, compared to a loss of $2.87 million and $0.04 in the previous year's quarter.
SIGA's revenue and EPS for the fiscal year ending December 2024 are expected to increase 14.7% and 6.3% year-over-year to $160.46 million and $1.01, respectively.
The stock has gained 52.5% over the past three months and 142.3% over the past nine months to close the last trading session at $11.97.
SIGA's positive fundamentals are mirrored in its POWR Ratings. It has an overall rating of B, equating to a Buy in our proprietary rating system.
SIGA has an A grade for Value and Quality and a B for Growth. It is ranked #14 out of 362 stocks in the Biotech industry.
Beyond what we stated above, we also have given SIGA grades for Momentum, Stability, and Sentiment. Get all the SIGA ratings <a href="https://stocknews.com/stock/SIGA/">here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;
&nbsp;

<hr />
SIGA shares fell $11.97 (-100.00%) in premarket trading Thursday. Year-to-date, SIGA has gained 113.75%, versus a 15.12% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Aanchal Sugandh</h2> <img src='https:/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg' style="float:left; padding:5px;width:125px;">Aanchal's passion for financial markets drives her work as an investment analyst and journalist. She earned her bachelor's degree in finance and is pursuing the CFA program.

She is proficient at assessing the long-term prospects of stocks with her fundamental analysis skills. Her goal is to help investors build portfolios with sustainable returns.<a href="https://stocknews.com/authors/?author=aanchal-sugandh">More...</a>The post <a href=https://stocknews.com/news/siga-anik-thtx-3-small-cap-healthcare-stocks-with-breakthrough-potential/>3 Small-Cap Healthcare Stocks With Breakthrough Potential</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Small-Cap Healthcare Stocks With Breakthrough Potential

Theratechnologies (TSE:TH) has released an update. Theratechnologies has announced a potential early 2025 supply disruption for EGRIFTA SV due to a...

Theratechnologies Faces EGRIFTA SV Supply Disruption

Theratechnologies (TSE:TH) has released an update. Theratechnologies Inc. faces a potential early 2025 supply disruption for its EGRIFTA SV product...

Theratechnologies Braces for Supply Disruption

Theratechnologies (TSE:TH) has released an update. Theratechnologies has reported a robust financial performance for Q3 2024, with an 8% increase i...

Theratechnologies Celebrates Strong Q3 Results and Raised Outlook

Theratechnologies Inc. (THTX) Q3 2024 Earnings Call Transcript

Theratechnologies (THTX – Research Report) received a Hold rating and price target from JonesTrading analyst Justin Walsh today. The company's shar...

Theratechnologies (THTX) was downgraded to a Hold Rating at JonesTrading

Theratechnologies (THTX) announced the resubmission of its supplemental Biologics License Application, sBLA, to the U.S. Food and Drug Administrati...

Theratechnologies submits updated tesamorelin F8 forumlation for FDA review

Theratechnologies (TSE:TH) has released an update. Theratechnologies has resubmitted a supplemental Biologics License Application to the FDA for it...

Theratechnologies Resubmits Tesamorelin Application to FDA

Theratechnologies resubmits BLA for new tesamorelin formulation

ANIK

SIGA

THTX

Press Releases

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

Earnings

Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024

Theratechnologies to Present at Upcoming Investor Conferences in September

Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025

Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update

Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV

Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024

Health Care

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV

Comments

Theratechnologies

Theratechnologies (THTX) Opzioni

Theratechnologies (NASDAQ:THTX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO